CardioGenesis Prepares For New Trial Of Percutaneous Laser Angina Device
This article was originally published in The Gray Sheet
Executive Summary
CardioGenesis credits the recent regulatory progress of its Axcis laser percutaneous myocardial channeling (PMC) system to the contributions of Syncardia CEO Marvin Slepian, MD